Major cardiovascular events and associated factors among routine hemodialysis patients with end-stage renal disease at tertiary care hospital in Somalia

Introduction Cardiovascular complications are the most significant cause of death in patients undergoing routine hemodialysi (HD) with end-stage renal disease (ESRD). The main objective of this study is to determine the significant cardiac events and risk factors in patients undergoing routine hemodialysis in Somalia. Methods We carried out a cross-sectional retrospective study in a single dialysis center in Somalia. Two hundred out of 224 were included. All of them had ESRD and were on hemodialysis during the study period between May and October 2021. The records of all patients were reviewed, and the following parameters were analyzed socio-demographic factors, risk factors for cardiovascular disease, and the presence of cardiovascular diseases. Results The mean age was 54 ± 17.5 years (range 18–88 years), and 106 (53%) patients were males. The prevalence of a cardiovascular disease among hemodialysis patients was 29.5%. Moreover, the distribution of cardiovascular diseases was different; heart failure was the most common, about 27.1%, followed by coronary artery disease (17%), pericarditis and pericardial-effusion (13.6%), dysrhythmia (10.2%), cerebrovascular-accident (8.5%), and peripheral vascular disease (3.4%). About 176 (88%) participants had at least one modifiable cardiovascular risk factor. The most common modifiable cardiovascular risk factor was hypertension (n = 45, 25.1%), followed by anemia (n = 28, 15.6%) and diabetes (n = 26, 14.5%). Younger (18–30) participants were six times less likely to have cardiovascular events among hemodialysis than older age 0.4 (0.11–1.12). Conclusion Low prevalence rate of cardiovascular complications was confirmed in ESRD patients receiving hemodialysis in the main HD center in Somalia. Diabetes, anemia, and hypertension were the highest significant risk factors for CVD in HD patients with ESRD in Somalia.

[1]  B. Derseh,et al.  Mortality and predictors of Chronic Kidney Diseases (CKD) in selected dialysis centers in Addis Ababa, Ethiopia , 2022, medRxiv.

[2]  A. Jardine,et al.  A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients , 2020, Kidney international reports.

[3]  M. Petersen,et al.  The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study , 2020, PloS one.

[4]  Y. Khader,et al.  Risk Factors for End-Stage Renal Failure Among Patients on Hemodialysis in Aljomhory Hospital, Sa’adah Governorate, Yemen: Hospital-Based Case-Control Study , 2019, JMIR public health and surveillance.

[5]  I. Ssinabulya,et al.  Utility of albumin to creatinine ratio in screening for microalbuminuria among newly diagnosed diabetic patients in Uganda: a cross sectional study , 2019, African health sciences.

[6]  S. Abdulla,et al.  The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa , 2018, PloS one.

[7]  M. Daha,et al.  Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients , 2018, Front. Immunol..

[8]  Shigeru Tanaka,et al.  Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Shuzo Kobayashi Cardiovascular Events in Hemodialysis Patients: Challenging against Vascular Calcification , 2017, Annals of vascular diseases.

[10]  N. Lloberas,et al.  Association of ANRIL gene polymorphisms with major adverse cardiovascular events in hemodialysis patients. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[11]  P. Kerr,et al.  Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices , 2016, The Lancet.

[12]  A. Subbiah,et al.  Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup , 2016, Heart Asia.

[13]  C. Lim,et al.  Predictor of cardiovascular risks in end stage renal failure patients on maintenance dialysis , 2015, Pakistan journal of medical sciences.

[14]  A. Kengne,et al.  Acute hemodialysis complications in end‐stage renal disease patients: The burden and implications for the under‐resourced Sub‐Saharan African health systems , 2012, Hemodialysis international. International Symposium on Home Hemodialysis.

[15]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[16]  A. Kengne,et al.  Referral of Patients with Kidney Impairment for Specialist Care in a Developing Country of Sub-Saharan Africa , 2009, Renal failure.

[17]  R. Foley,et al.  Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. , 2005, Journal of the American Society of Nephrology : JASN.

[18]  Tom Chan,et al.  Identifying patients with chronic kidney disease from general practice computer records. , 2005, Family practice.

[19]  M. Rocco,et al.  Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. , 2004, Kidney international.

[20]  A. Jardine,et al.  Cardiovascular complications of renal disease , 2001, Heart.

[21]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[23]  N. Vaziri,et al.  Cardiac Pathology in Patients with End-Stage Renal Disease Maintained on Hemodialysis , 1993, The International journal of artificial organs.

[24]  S. Rostand,et al.  Dialysis-associated ischemic heart disease: insights from coronary angiography. , 1984, Kidney international.

[25]  B. Scribner,et al.  Accelerated atherosclerosis in prolonged maintenance hemodialysis. , 1974, The New England journal of medicine.

[26]  N. Powe,et al.  Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. , 2017, Journal of the American Society of Nephrology : JASN.

[27]  Xinling Liang,et al.  Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients , 2013, International Urology and Nephrology.

[28]  P. Aljama,et al.  [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)]. , 2005, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.